Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.

Masahiro Iwasaku Uchino JunjiKenji ChibanaShigeru TanzawaTakahiro YamadaKazunori TobinoYasuki UchidaTakashi KijimaKatsumi NakatomiMiiru IzumiNobuyo TamiyaHideharu KimuraMasaki FujitaRyoichi HondaChieko TakumiTadaaki YamadaYoshiko KanekoFumiaki KiyomiTakayama Koichi

Published in: Cancer medicine (2023)

Although the prophylactic strategy was ineffective, the adherence to prophylactic medication was quite good. Patient education regarding prophylaxis is important and can lead to improved treatment continuity.

Keyphrases

epidermal growth factor receptor
healthcare
advanced non small cell lung cancer
tyrosine kinase
emergency department
high glucose
soft tissue
combination therapy
replacement therapy
skeletal muscle
study protocol
smoking cessation